{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:20:59Z","timestamp":1791253259229,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jconrel.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T05:58:16Z","timestamp":1625723896000},"page":"572-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification"],"prefix":"10.1016","volume":"336","author":[{"given":"Fengmei","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haini","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linglin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhepeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.07.008_bb0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0010","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s13346-017-0395-2","article-title":"Vaginal drug delivery for the localised treatment of cervical cancer","volume":"7","author":"Major","year":"2017","journal-title":"Drug Deliv. Trans. Res."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a sticky situation: bypassing the mucus barrier for improved local drug delivery","volume":"27","author":"Zierden","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0020","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/adma.201201800","article-title":"Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery","volume":"24","author":"Ensign","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0025","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1039\/C9BM00756C","article-title":"Use of multifunctional composite nanofibers for photothermalchemotherapy to treat cervical cancer in mice","volume":"7","author":"Wang","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0030","doi-asserted-by":"crossref","first-page":"1903208","DOI":"10.1002\/smll.201903208","article-title":"A paclitaxel-based mucoadhesive nanogel with multivalent interactions for cervical cancer therapy","volume":"15","author":"Qian","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2016.10.017","article-title":"Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer","volume":"109","author":"B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12951-016-0185-x","article-title":"Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer","volume":"14","author":"Sims","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0045","doi-asserted-by":"crossref","first-page":"110635","DOI":"10.1016\/j.msec.2020.110635","article-title":"The application of nanomaterial science in the formulation a novel antibiotic: assessment of the antifungal properties of mucoadhesive clotrimazole loaded nanofiber versus vaginal films","volume":"110","author":"Nematpour","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bmcl.2016.11.083","article-title":"Intelligent substance delivery into cells using cell-penetrating peptides","volume":"27","author":"Tashima","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","article-title":"Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers","volume":"60","author":"Torchilin","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0060","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0065","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0070","first-page":"609","article-title":"Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery","volume":"10","author":"Vasconcelos","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.apsb.2015.11.005","article-title":"Injected nanocrystals for targeted drug delivery","volume":"6","author":"Lu","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejon.2008.10.003","article-title":"Docetaxel-related side effects and their management","volume":"13","author":"Baker","year":"2009","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0085","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1021\/nn4037317","article-title":"Modular design of redox-responsive stabilizers for nanocrystals","volume":"7","author":"Fuhrmann","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/pharmaceutics11010015","article-title":"Enhanced delivery of imatinib into vaginal mucosa via a new positively charged nanocrystal-loaded in situ hydrogel formulation for treatment of cervical cancer","volume":"11","author":"Ci","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2018.12.023","article-title":"RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability","volume":"556","author":"Huang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/molecules25030604","article-title":"Synergistic antitumor effects on drug-resistant breast cancer of paclitaxel\/lapatinib composite nanocrystals","volume":"25","author":"Wang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.colsurfb.2017.09.012","article-title":"PEGylated polydopamine-coated magnetic nanoparticles for combined targeted chemotherapy and photothermal ablation of tumour cells","volume":"160","author":"Xue","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcis.2016.09.003","article-title":"A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability","volume":"485","author":"Wang","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.apsb.2017.03.002","article-title":"Amino-functionalized poloxamer 407 with both mucoadhesive and thermosensitive properties: preparation, characterization and application in a vaginal drug delivery system","volume":"7","author":"Ci","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"Owen","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0125","first-page":"458","article-title":"In vivo evaluation of an in-situ hydrogel system for vaginal administration","volume":"69","author":"Li","year":"2014","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejps.2009.02.022","article-title":"Effect of carrageenan on poloxamer-based in situ gel for vaginal use: improved in vitro and in vivo sustained-release properties","volume":"37","author":"Liu","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1039\/C3MH00106G","article-title":"Protein corona formation around nanoparticles - from the past to the future","volume":"1","author":"Pino","year":"2013","journal-title":"Mater. Horizons"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0140","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.apsb.2017.03.003","article-title":"In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models","volume":"7","author":"Liu","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0150","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.3390\/ijms21218266","article-title":"The cervicovaginal mucus barrier","volume":"21","author":"Lacroix","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0155","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1021\/acs.biomac.6b00054","article-title":"Phenylboronic acid based polymeric micelles for mucoadhesive anterior segment ocular drug delivery","author":"Prosperi-Porta","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0160","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1021\/acsnano.9b04436","article-title":"Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine","volume":"13","author":"Cheng","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0170","doi-asserted-by":"crossref","first-page":"30943","DOI":"10.1021\/acsami.7b09774","article-title":"Deposition and adhesion of polydopamine on surfaces of varying wettability","volume":"9","author":"Zhang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0175","doi-asserted-by":"crossref","first-page":"10790","DOI":"10.1039\/C4NR07450E","article-title":"Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis","volume":"7","author":"Zhang","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0180","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2016.12.029","article-title":"PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha","volume":"113","author":"J\u00f8raholmen","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.07.008_bb0185","doi-asserted-by":"crossref","first-page":"111287","DOI":"10.1016\/j.colsurfb.2020.111287","article-title":"Mucus-penetrating PEGylated polysuccinimide-based nanocarrier for intravaginal delivery of siRNA battling sexually transmitted infections","volume":"196","author":"Currie","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0190","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/IJN.S115136","article-title":"Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer","volume":"12","author":"Bo","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.07.008_bb0195","first-page":"5452","article-title":"TAT-mediated si-hWAPL inhibits the invasion and metastasis of cervical cancer stem cells","volume":"14","author":"Gong","year":"2017","journal-title":"Exp. Therap. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921003515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921003515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:04:56Z","timestamp":1759161896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921003515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"alternative-id":["S0168365921003515"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.07.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced mucosal penetration and efficient inhibition efficacy against cervical cancer of PEGylated docetaxel nanocrystals by TAT modification","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}